Gnubiotics Sciences Competitors

Nestlé Health Science is a leader in the science of nutrition, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer care, medical nutrition and pharmaceutical therapies. Headquartered in Switzerland, we have more than 12,000 employees around the world, with products available in more than 140 countries. We see opportunities to improve health through nutrition everywhere. Our expertise areas of active lifestyle nutrition, including vitamins, minerals, herbals and supplements (VMHS), medical nutrition, and pharmaceutical solutions, are rooted in science and cover every facet of health: prevention, maintenance, and treatment. We are redefining the way consumers and healthcare professionals approach the management of health. With a focus on areas including food allergies, metabolic health, gastrointestinal health, healthy aging, and adult acute care, we leverage our extensive research and development networks to unlock the power of nutrition. The wide range of solutions we offer across the spectrum of life has one common denominator: science-based products that help people live their best lives.

Danone is a global leader in the food and beverage industry, operating in three fast-growing, health-focused categories: Essential Dairy & Plant-Based, Waters, and Specialized Nutrition. True to its mission—bringing health through food to as many people as possible—Danone promotes healthier and more sustainable eating habits, while striving to deliver measurable impact across nutritional, social, societal, and environmental dimensions. In 2026, Danone continues the rollout of the second chapter of its Renew strategy, aimed at strengthening its competitiveness, accelerating its transformation, and creating sustainable value. With 90,000 employees and a presence in over 120 markets, Danone generated €27.283 billion in revenue in 2025, reflecting solid growth driven by a positive volume/mix globally. Its portfolio includes iconic international brands—Actimel, Activia, Alpro, Aptamil, Danette, Danonino, evian, Volvic, Nutricia, among others—as well as strong local and regional brands. Danone is listed on Euronext Paris and present on the OTCQX platform through an ADR program. Already included in numerous sustainability indexes, the Group reached a major milestone by becoming fully B Corp™ certified in 2025, underscoring its global commitment to a responsible business model. **Please note: all official Danone job opportunities are published on our Careers website: https://careers.danone.com/ Danone will never contact candidates using non-@danone.com email addresses. Please stay vigilant and never share personal information if you are unsure of the source.

Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. We are also conducting research to inform further development of microbiome therapeutics for ulcerative colitis. For more information, please visit http://www.serestherapeutics.com/ .